TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 78 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $2,000 | -99.0% | 25 | -99.1% | 0.00% | -100.0% |
Q3 2019 | $204,000 | -41.5% | 2,698 | -33.9% | 0.00% | -33.3% |
Q2 2019 | $349,000 | +27.8% | 4,083 | +61.6% | 0.01% | -33.3% |
Q1 2019 | $273,000 | +31.2% | 2,527 | +2.6% | 0.01% | -10.0% |
Q4 2018 | $208,000 | -1.9% | 2,463 | +14.3% | 0.01% | -16.7% |
Q3 2018 | $212,000 | -55.6% | 2,154 | -47.7% | 0.01% | -50.0% |
Q2 2018 | $477,000 | +0.2% | 4,122 | -14.4% | 0.02% | -14.3% |
Q1 2018 | $476,000 | -56.2% | 4,818 | -53.6% | 0.03% | -51.7% |
Q4 2017 | $1,086,000 | +249.2% | 10,373 | +377.4% | 0.06% | +222.2% |
Q1 2016 | $311,000 | -27.5% | 2,173 | -21.6% | 0.02% | -28.0% |
Q4 2015 | $429,000 | -28.3% | 2,773 | -33.7% | 0.02% | -16.7% |
Q3 2015 | $598,000 | +113.6% | 4,185 | +114.9% | 0.03% | +114.3% |
Q2 2015 | $280,000 | -59.5% | 1,947 | -60.3% | 0.01% | -58.8% |
Q1 2015 | $692,000 | -9.9% | 4,910 | -5.2% | 0.03% | -17.1% |
Q4 2014 | $768,000 | +129.9% | 5,182 | +138.7% | 0.04% | +105.0% |
Q3 2014 | $334,000 | – | 2,171 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
ARK Investment Management | 55,566 | $2,404,000 | 0.01% |